Neuvivo, a biopharmaceutical company developing breakthrough novel therapies for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases, has appointed Mark Henderson, PhD, as the company’s new Vice President of Manufacturing.   In this role, Dr. Henderson will oversee manufacturing, quality assurance and drug formulation, including for NP001—Neuvivo’s investigational treatment for ALS—which has been granted Orphan Drug and Fast Track Designations by the FDA.   &...